DOCSLIB.ORG

Rite Aid Corporation and the Jean Coutu Group

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rite Aid Corporation and the Jean Coutu Group Federal Register / Vol. 72, No. 111 / Monday, June 11, 2007 / Notices 32099 April 1, 2004 respectively. On March • FCSIC Financial Report. ACTION: Proposed Consent Agreement. 31, 2005, EPA approved Louisiana’s • Report on Insured Obligations. 2002 listing of 442 water body-pollutant • Quarterly Report on Annual SUMMARY: The consent agreement in this combinations and associated priority Performance Plan. matter settles alleged violations of federal law prohibiting unfair or rankings and Louisiana’s 2004 listing of C. New Business 444 water body-pollutant combinations deceptive acts or practices or unfair • and associated priority rankings. EPA Mid-year Review of Insurance methods of competition. The attached disapproved Louisiana’s 2002 listing Premium Rates. Analysis to Aid Public Comment decisions not to list 44 water quality describes both the allegations in the Closed Session draft complaint and the terms of the limited segments and associated • pollutants (or 69 water body-pollutant FCSIC Report on System consent order -- embodied in the consent agreement -- that would settle combinations) and Louisiana’s 2004 Performance. these allegations. listing decisions not to list 14 water Dated: June 5, 2007. quality limited segments and associated Roland E. Smith, DATES: Comments must be received on pollutants (or 17 water body-pollutant Secretary, Farm Credit System Insurance or before July 9, 2007. combinations). EPA identified these Corporation Board. ADDRESSES: Interested parties are additional waters and pollutants along [FR Doc. E7–11168 Filed 6–8–07; 8:45 am] invited to submit written comments. Comments should refer to ‘‘Rite Aid and with priority rankings for inclusion on BILLING CODE 6710–01–P the 2002 and 2004 Section 303(d) Lists. The Jean Coutu Group, File No. 061 0257,’’ to facilitate the organization of Dated: May 31, 2007. comments. A comment filed in paper FEDERAL HOUSING FINANCE BOARD Miguel I. Flores form should include this reference both Director, Water Quality Protection Division, in the text and on the envelope, and Region 6. Sunshine Act Meeting Notice; Announcing a Partially Open Meeting should be mailed or delivered to the [FR Doc. E7–11209 Filed 6–8–07; 8:45 am] of the Board of Directors following address: Federal Trade BILLING CODE 6560–50–P Commission/Office of the Secretary, TIME AND DATE: The open meeting of the Room 135-H, 600 Pennsylvania Avenue, Board of Directors is scheduled to begin NW, Washington, D.C. 20580. FARM CREDIT SYSTEM INSURANCE at 10 a.m. on Wednesday, June 13, 2007. Comments containing confidential CORPORATION The closed portion of the meeting will material must be filed in paper form, follow immediately the open portion of must be clearly labeled ‘‘Confidential,’’ Regular Meeting the meeting. and must comply with Commission AGENCY: Farm Credit System Insurance PLACE: Board Room, First Floor, Federal Rule 4.9(c). 16 CFR 4.9(c) (2005).1 The Corporation Board. Housing Finance Board, 1625 Eye FTC is requesting that any comment SUMMARY: Notice is hereby given of the Street, NW., Washington, DC 20006. filed in paper form be sent by courier or regular meeting of the Farm Credit STATUS: The first portion of the meeting overnight service, if possible, because System Insurance Corporation Board will be open to the public. The final U.S. postal mail in the Washington area (Board). portion of the meeting will be closed to and at the Commission is subject to Date and Time: The meeting of the the public. delay due to heightened security Board will be held at the offices of the precautions. Comments that do not MATTER TO BE CONSIDERED AT THE OPEN Farm Credit Administration in McLean, contain any nonpublic information may PORTION: Final Rule: Financial Interests Virginia, on June 12, 2007, from 9 a.m. instead be filed in electronic form as for Appointive Directors. until such time as the Board concludes part of or as an attachment to email its business. MATTER TO BE CONSIDERED AT THE CLOSED messages directed to the following email PORTION: Periodic Update of FOR FURTHER INFORMATION CONTACT: box: [email protected]. Examination Program Development and Roland E. Smith, Secretary to the Farm The FTC Act and other laws the Supervisory Findings. Credit System Insurance Corporation Commission administers permit the Board, (703) 883–4009, TTY (703) 883– CONTACT PERSON FOR MORE INFORMATION: collection of public comments to 4056. Shelia Willis, Paralegal Specialist, consider and use in this proceeding as Office of General Counsel, at 202–408– ADDRESSES: Farm Credit System appropriate. All timely and responsive 2876 or [email protected]. Insurance Corporation, 1501 Farm public comments, whether filed in Credit Drive, McLean, Virginia 22102. Dated: June 6, 2007. paper or electronic form, will be SUPPLEMENTARY INFORMATION: Parts of By the Federal Housing Finance Board. considered by the Commission, and will this meeting of the Board will be open Neil R. Crowley, be available to the public on the FTC to the public (limited space available) Acting General Counsel. website, to the extent practicable, at and parts will be closed to the public. [FR Doc. 07–2890 Filed 6–6–07; 4:36 pm] www.ftc.gov. As a matter of discretion, the FTC makes every effort to remove In order to increase the accessibility to BILLING CODE 6725–01–P Board meetings, persons requiring home contact information for assistance should make arrangements in individuals from the public comments it receives before placing those comments advance. The matters to be considered FEDERAL TRADE COMMISSION at the meeting are: [File No. 061 0257] 1 The comment must be accompanied by an Open Session explicit request for confidential treatment, Rite Aid Corporation and The Jean including the factual and legal basis for the request, A. Approval of Minutes Coutu Group (PJC), Inc.; Analysis of and must identify the specific portions of the • comment to be withheld from the public record. April 12, 2007 (Open and Closed) The Agreement Containing Proposed The request will be granted or denied by the B. Business Reports. Consent Order to Aid Public Comment Commission’s General Counsel, consistent with applicable law and the public interest. See • Investment Program Review. AGENCY: Federal Trade Commission. Commission Rule 4.9(c), 16 CFR 4.9(c). VerDate Aug<31>2005 15:28 Jun 08, 2007 Jkt 211001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\11JNN1.SGM 11JNN1 cprice-sewell on PROD1PC67 with NOTICES 32100 Federal Register / Vol. 72, No. 111 / Monday, June 11, 2007 / Notices on the FTC website. More information, and will decide whether it should customers generally pay the full posted including routine uses permitted by the withdraw from the agreement or make or list price set by a pharmacy for a Privacy Act, may be found in the FTC’s the proposed Order final. prescription drug or an amount privacy policy, at http://www.ftc.gov/ The purpose of this analysis is to reflecting a discount off of those prices. ftc/privacy.htm. invite public comment on the proposed The evidence indicates that the sale of FOR FURTHER INFORMATION CONTACT: consent Order. This analysis does not pharmacy services to cash customers is Thomas Cohn, Leonard Gordon, or constitute an official interpretation of a separate market from the sale of Jonathan Platt (212) 607-2829, Northeast the agreement and proposed Order, and pharmacy services to customers covered Regional Office, Federal Trade does not modify the terms in any way. by third party payors. This is consistent Commission, One Bowling Green, Suite Further, the proposed consent Order has with prior Commission investigations 318, New York, New York 10004. been entered into for settlement regarding pharmacy services. SUPPLEMENTARY INFORMATION: Pursuant purposes only, and does not constitute The evidence indicates that pricing in to section 6(f) of the Federal Trade an admission by the Proposed the cash prescription market is not Commission Act, 38 Stat. 721, 15 U.S.C. Respondents that they violated the law constrained by competitive conditions 46(f), and § 2.34 of the Commission or that the facts alleged in the in the third party payor prescription Rules of Practice, 16 CFR 2.34, notice is Complaint against the Respondents market, nor by mail order pharmacies or hereby given that the above-captioned (other than jurisdictional facts) are true. discount cards. Cash customers pay consent agreement containing a consent On August 23, 2006, Rite Aid entered prices that are consistently higher than order to cease and desist, having been into a Stock Purchase Agreement prices on the same drugs paid for by filed with and accepted, subject to final whereby Rite Aid would acquire Jean third party payors, and there is a approval, by the Commission, has been Coutu’s Eckerd and Brooks retail significant disparity in profit margins placed on the public record for a period pharmacy chains in exchange for between sales to cash customers and of thirty (30) days. The following approximately $3.5 billion worth of sales to customers covered by third Analysis to Aid Public Comment cash and stock. As a result of the party payors. Cash customers are most describes the terms of the consent transaction, Rite Aid would hold 100% likely unable to purchase health agreement, and the allegations in the of the common and preferred shares of insurance or obtain health benefits from complaint. An electronic copy of the The Jean Coutu Group USA, Inc., and an employer in response to a post- full text of the consent agreement Jean Coutu would acquire merger price increase for cash prescriptions. package can be obtained from the FTC approximately 30% of the voting Evidence indicates that cash Home Page (for June 4, 2007), on the securities of Rite Aid. customers typically do not travel far to World Wide Web, at http://www.ftc.gov/ II.
Load more

Recommended publications
  • Come Exhibit with Us
    Store Brands Got The Power Come Exhibit With Us 2011 2010 26.0% 2009 25.0% 2008 23.7% 2007 22.3% 21.2% November 14-16 Chicago Presented by the Private Label Manufacturers Association Store Brands ll across the country, store brands power is driving big increases in store brands sales. A New categories. New merchandising ideas. New package designs. New shelf allocation. Store brands are reaching unheard of levels of consumer popularity and retailer commitment. For manufacturers, store brands power is the power to compete with big national brands in category after category without big advertising budgets and promotion allowances. It’s the power to make a small and medium-size company important to retailers. It’s the power to market your products to millions of consumers. It means new opportunities for your business. Store brands power is growing, too. According to GfK Roper, 57% of all shoppers now say that they purchase store brands frequently, up from 36% ten years ago. Moreover, 9 out of 10 consumers say that store brands are now as good as or better than national brands and one-third of all shoppers expect to buy more store brands in the year ahead. November Got The Power THE SHOW FOR STORE BRANDS MORE THAN PRODUCTS PLMA gives you the chance to show your power. For PLMA’s annual show is more than just products, though. nearly 30 years, PLMA’s Private Label Trade Show has PLMA’s Innovation Hall features the latest software and been the place where retailers and suppliers meet to technology to make business more efficient.
    [Show full text]
  • The Jean Coutu Group (Pjc) Inc
    THE JEAN COUTU GROUP (PJC) INC. ANNUAL INFORMATION FORM Financial year ended May 31, 2002 October 18, 2002 TABLE OF CONTENTS ITEM 1 - INCORPORATION................................................................................................................................... 3 1.1 INCORPORATION OF THE ISSUER ................................................................................................................... 3 1.2 CAPITAL STRUCTURE.................................................................................................................................... 3 1.3 SUBSIDIARIES................................................................................................................................................ 4 ITEM 2 - GENERAL DEVELOPMENT OF THE BUSINESS.............................................................................. 4 2.1 HISTORY AND PROFILE ................................................................................................................................. 4 2.2 PRINCIPAL DEVELOPMENT AND ACQUISITIONS OF THE LAST FIVE YEARS ................................................... 5 ITEM 3 - DESCRIPTION OF ACTIVITIES ........................................................................................................... 6 3.1 FRANCHISING................................................................................................................................................ 6 3.1.1 Franchising Business ....................................................................................................................
    [Show full text]
  • Clinique Now More Accessible Than Ever Famous Brand Arriving at Jean Coutu
    Press Release For Immediate Release Clinique now more accessible than ever Famous brand arriving at Jean Coutu Varennes, Quebec, May 12, 2017 – The Jean Coutu Group (PJC) Inc. (the "Corporation" or the "Jean Coutu Group") announces the arrival of the famous Clinique brand in several of its affiliated stores in Quebec and New Brunswick. From the outset, Clinique has set itself apart through products adapted for every skin concern. In order to reach a wider clientele, of both women and men, the products are now available in most areas of the province (see list). As of now, all the products can also be purchased online at cliniqueproducts.jeancoutu.com. "We are pleased to offer Clinique products, previously available only in large centres, over a wider territory. The implementation will be staggered over three years. 54 stores will carry the brand by August 2017," said Christian Comtois, Senior Manager, Cosmetics at Jean Coutu Group. "As the high end skincare brand in Canada, Clinique is pleased to partner with Jean Coutu, the most admired and respected retailer in Quebec. We are convinced that Clinique’s beauty vision, based on simple routines that give astonishing results, is completely in line with Jean Coutu’s customers throughout the province. We look forward to the future and this important association between two iconic brands," said Artur Klepacz, Brand General Manager at Clinique Canada and LAB SERIES Skincare For Men. A wide range of products Jean Coutu will carry the popular skincare lines such as the famous 3-Step system, Acne Solutions products, the men’s line, the Smart franchise, anti-aging skincare and several recent products.
    [Show full text]
  • 2017 Annual Report
    2017 ANNUAL REPORT TABLE OF CONTENTS MESSAGE TO SHAREHOLDERS ................................................................................................................................. 2 CORPORATE PROFILE ............................................................................................................................................. 3 MANAGEMENT'S DISCUSSION AND ANALYSIS ........................................................................................................... 8 1. GENERAL INFORMATION ...................................................................................................................... 8 2. DEFINITIONS ....................................................................................................................................... 8 3. SELECTED ANNUAL INFORMATION FOR FISCAL YEARS 2017, 2016 AND 2015 ......................................... 9 4. OPERATING SEGMENTS PERFORMANCE FOR FISCAL YEARS 2017 AND 2016 ........................................ 11 5. QUARTERLY RESULTS ....................................................................................................................... 12 6. INFORMATION ON THE PJC NETWORK OF FRANCHISED STORES ........................................................... 14 7. LIQUIDITY AND CAPITAL RESOURCES .................................................................................................. 15 8. FINANCIAL INSTRUMENTS AND OFF-BALANCE SHEET ARRANGEMENTS .................................................. 18 9. RELATED PARTY TRANSACTIONS
    [Show full text]
  • 1 CANADA (Class Action) SUPERIOR COURT PROVINCE of QUEBEC DISTRICT of MONTREAL M. HÉBER
    1 CANADA (Class Action) SUPERIOR COURT PROVINCE OF QUEBEC ____________________________________ DISTRICT OF MONTREAL M. HÉBERT NO: 500-06-001085-204 Petitioner -vs.- ANGITA PHARMA INC., legal person duly incorporated, having its head office at 504- 1570 rue Ampère, City of Boucherville, Province of Quebec, J4B 5Z5 and THE JEAN COUTU GROUP (PJC) INC., legal person duly incorporated, having its head office at 11011 boul. Maurice-Duplessis, City of Montreal, Province of Quebec, H1C 1V6 Respondents ____________________________________ ____________________________________________________________________ APPLICATION TO AUTHORIZE THE BRINGING OF A CLASS ACTION & TO APPOINT THE PETITIONER AS REPRESENTATIVE (Art. 574 C.C.P. and following) ____________________________________________________________________ TO ONE OF THE HONOURABLE JUSTICE OF THE SUPERIOR COURT, SITTING IN AND FOR THE DISTRICT OF MONTREAL, YOUR PETITIONER STATE AS FOLLOWS: I. GENERAL PRESENTATION A) The Action 1. Petitioner wishes to institute a class action on behalf of the following class, of which she is a member, namely: • All persons who have a pharmacy record that was accessed by Angita Pharma or any other group to be determined by the Court; 2. This is a case of the intentional violation of Class Members’ privacy rights; Respondent Angita Pharma was given access to customers’ confidential pharmacy 2 records for profit. This access was unauthorized and illegal; Respondent Jean Coutu was reckless or grossly negligent for failing to put in place safeguards that would prevent this type of conduct from being able to take place; 3. Over 200 pharmacists (73 of which are affiliated with Jean Coutu) have been accused by their professional order, the Ordre des pharmaciens du Québec, of allowing Respondent Angita Pharma access to their clients’ confidential files; 4.
    [Show full text]
  • Acts of the General Assembly of South-Carolina
    ACTS AND JOINT R ESOLUTIONS OFHE T GENERAL A SSEMBLY OFHE T Statef o South Carolina, PASSEDT A THE REGULAR S ESSION OF 1903. PRINTEDY b ORDER OF THE GENERAL ASSEMbLY AND DESIGNED TO FORM A PART OF THE TWENTY-FOURTH VOLUME OF THE 8TATUTE8 AT LARGE, COMMENCING WITH THE ACTS OF THE REGULAR SESSION OF 1906. COLUMBIA, S . C. THE STATE COMPANY, STATE PRINTER8. 1608. LISTF O ACTSND A JOINT RESOLUTIONS, 1903. —PART L GENERAL LAWS. PAGE. No. 1 . An Act to further define connecting lines of common carriers ando t fix their liabilities 1 No. 2 . An Act to ratify the amendment to Section 11, Article VII., of the Constitution of 1895, relating to Counties and County gov ernment 2 l No. 3 . An Act granting to the United States the title of this State to, and the jurisdiction of this State over, certain lands on Sulli van's Island, in Charleston County, for military purposes. ... 4 No. 4 . An Act granting to the United States of America the title of this State to, and the jurisdiction of this State over, certain lands in Charleston County needed for "improving the inland water ways between Charleston harbor and a point opposite Mc- Clellanville," i n said County 6 No. 5 . An Act to supply bound copies of the Code of Laws of South Carolina, 1902, to certain members of the General Assembly, and to the Coroners of this State 7 No. 6 . An Act to abolish the office of Phosphate Inspector and to de volve the duties heretofore imposed on him on the Board of Phosphate Commissioners 8 No.
    [Show full text]
  • Market Study Pharmaceutical Sector in Mauritius
    MARKET STUDY PHARMACEUTICAL SECTOR IN MAURITIUS MS/004 Report of the Executive Director 08 June 2021 1 Table of Contents List of Figures ...................................................................................................................................... i List of Tables ....................................................................................................................................... i Executive Summary ............................................................................................................... 1 1. Introduction ...................................................................................................................... 4 A. Motivation and Scope of the Study ..................................................................................... 4 B. Structure of the Report ....................................................................................................... 5 2. Overview of healthcare sector and pharmaceutical sector in Mauritius ............................. 6 A. Healthcare sector ............................................................................................................... 6 B. The pharmaceutical sector .................................................................................................. 8 3. The Regulatory framework for the pharmaceutical industry ............................................ 12 A. Enabling Legislations .......................................................................................................
    [Show full text]
  • 2020 Corporate Responsibility Report
    Corporate Responsibility Report 2020 fiscal year Corporate profile Table of contents METRO is a food and pharmacy leader in Québec and Ontario Messages 2 - President and Chief Executive Officer - Vice President, Public Affairs and Communications Corporate responsibility at METRO 3 Sales of Network of Nearly Founded in 2019 Highlights 4 close to $18 1,601 90,000 Delighted customers 5 billion stores colleagues 1947 Respect for the environment 8 Strengthened communities 11 Empowered employees 14 Food Pharmacy About this report This corporate responsibility report covers the 2020 fiscal year: the 52-week period ending on September 26, 2020. The significant events that occurred between the end of the fiscal year and late December 2020 are also included. In this report, METRO refers to the corporation and Metro refers to the store banner. The report was reviewed by internal auditors but was not audited externally. Forward-looking information Throughout this report, we used statements that may constitute forward-looking 953 food stores 648 drugstores information. In general, any statement in this report that does not constitute Québec historical fact may be considered a forward-looking statement. The forward- Discount Neighbourhood Specialized 377 looking statements that may be set out in this report refer to hypotheses on the PJC Jean Coutu Supermarkets stores stores stores 537 Canadian food and pharmacy industries, targets, the economy in general and our PJC Santé 2016–2020 corporate responsibility plan. PJC Santé Beauté Québec 196 98 53 22 These forward-looking statements do not provide any guarantees as to the Metro Super C Marché Richelieu Première 160 future performance of the Corporation and are subject to known and unknown 680 Brunet Metro Plus Moisson risks and uncertainties that could cause the outcome to differ significantly.
    [Show full text]
  • International Student Guide
    Academy of Fine Arts in Warsaw erasmus student guide Visa 34 Insurance 34 Cost of living 35 About the Academy 06 Accommodation 36 Contact information 07 Emergency numbers 37 Faculties and specializations 08 Health care 37 Public transport 38 Meals 41 Going out 42 Erasmus/Exchange students 16 Sightseeing 42 Regular students 21 Mini glossary 44 Tuition fees 23 Map 46 The Open Academy 24 Academic calendar 28 Orientation week 29 Study facilities 29 Some rules and regulations 30 HOW TO APPLY 15 APPLY HOW TO 2 33 LIVING IN WARSAW THE ACADEMY OF FINE ARTS IN WARSAW 05 OF FINE ARTS IN WARSAW THE ACADEMY 4 1 WITH US 27 STUDYING 3 THE ACADEMY OF FINE ARTS IN WARSAW THE ACADEMY 1 04 05 About the Academy Contact information The Academy of Fine Arts in Warsaw is one of the oldest and largest The Academy of Fine Arts In Warsaw art institutions of higher education in Poland. Krakowskie Przedmieście 5 00-068 Warsaw Academy traditions date back to the beginning of the twentieth www.asp.waw.pl century and the Warsaw School of Fine Arts. Destroyed during the Second World War and rebuilt afterwards, the Academy has Rector: Professor Adam Myjak operated under its present name since 1954. Deputy Rector for Student Affairs: Associated Professor Wojciech Zubala, Prof. ASP The Academy of Fine Arts in Warsaw provides art education in Deputy Rector for Art and Faculty Research: twenty eight different specializations and has nine faculties: Painting, Professor Paweł Nowak Graphic Arts, Sculpture, Interior Design, Design, Conservation Deputy Rector for Academy Development: and Restoration of Works of Art, Media Art, Stage Design and Associated Professor Jerzy Bogusławski, Prof.
    [Show full text]
  • The Legal and Regulatory Framework for Community Pharmacies in the WHO European Region
    The legal and regulatory framework for community pharmacies in the WHO European Region The legal and regulatory framework for community pharmacies in the WHO European Region ABSTRACT Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for community pharmacies and their activities in Europe. It presents the diverse approaches to community pharmacy licenses and to establishment of new pharmacies and their ownership. It also details the framework for community pharmacy operating requirements (including opening hours, workforce, premises and equipment, services provided and identification of a community pharmacy) and the types of activity undertaken. Provisions associated with possible alternative forms of dispensing medicines (over-the-counter medicines, prescription-only medicines, dispensing by medical doctors and online medicine sales) are also described. The report concludes with the possible key players involved in the legal and regulatory framework and outlines their missions and functions. Adoption of provisions from one country to another needs a full analysis of advantages and disadvantages and adoption into the local context and adjusted to the coherence of the national framework. Keywords COMMUNITY PHARMACY SERVICES – legislation and jurisprudence PHARMACIES – legislation and jurisprudence LICENSURE, PHARMACY EUROPE GOOD PHARMACY PRACTICE ACCESS TO MEDICINES ISBN 9789289054249 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
    [Show full text]
  • Or Carol Mcquillan Bsc ( Hons), Researcher and Software Developer
    Feasability study for the provision of cross border out of hours GP services Item Type Study Authors Moore, Adrian;Co-operation and Working Together (CAWT) Publisher Impact Publishers Download date 30/09/2021 23:42:05 Link to Item http://hdl.handle.net/10147/244585 Find this and similar works at - http://www.lenus.ie/hse , -.j.'i~ 'Inn>l"'lq "" V""'no l..lltUfl .( ...~ '_>.<;,--[Jo .i)fU>.'!"!\ 1"""11:< \}". ,-~;, " ';~""~':~_,, __"': .~ ...-:;._ .. :,,;-, :::,;" ,;, ;.;;.;c;",;",,:,,:, :;,;)~.,,~}J"i :l "x'::-f ;:.~.:. :t ':~: ~ , .'--::.- :~%::~~ :';:,::;: ';~i x: :O;,;:@::';~~: .:-., :t ; :::~~:::: ,r.;~"" -:~.: .?: "",' .. '-~ :'om'.: ,",' .', , :}:: ;:% '. -', ~ :S :",:' ;,;W'=- m q ::;;:: • ./w -.',' . ~::~::;4.. : . ::w:;::;_, _,w. ::3t<. '---'.~ , ::% :;:;:;~: Feasibility Study for the provision of Cross Border Out of Hours GP Services Authors: Adrian Moore, Carol McQuillan, Stephen McAlister, Joanna Freeman, Andrew W Mu rphy, Catherine Loughrey, Scott Brown © CAWT ISBN 0 948154 01 2 Printed & Published by Impact Publishers Co leraine & Ba llycastle Feasibility Study for th e provision of Cross Border Out of Hours GP Services CONTENTS page Foreword 3 Acknowledgements 4 Executive Summary 5 1. Introduction 7 1. 1 Background 7 1.2 A Socio-Economic Profile of the Irish Cross-border Region 11 2. Methodology 15 2.1 Terms of Reference 15 2.2 Geographical Issues 16 2.3 Tech nical Issues 16 2.4 Professional and Business Issues 16 2.5 Methodologies Employed 17 3. Geographical Issues 19 3.1 Objectives 19 3.2 Methods 19 3.3 Data 20 3.4 Current 'within jurisdiction' primary care centre catchment a rea~ 21 3.5 Cross border 'irrespective of jurisdiction' primary care centre catchment areas 23 3.6 Areas which would be suitable for cross border out of hours arrangements 24 3.7 Popul ations and estimated number of people residing in areas that are closer to a primary care centre outside their residential jurisdiction 25 3.8 Gains, loses and net differences in catchment populations for each primary ca re ce ntre 26 3.
    [Show full text]
  • Whaley Colin.Pdf (953.4Kb)
    Perspectives from Pharmacists, Prescribers and Patients on Sharing Medication Reason for Use by Colin Raymond Joseph Whaley A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Master of Science in Pharmacy Waterloo, Ontario, Canada, 2020 ©Colin Whaley 2020 Author's Declaration This thesis consists of material all of which I authored or co-authored: see Statement of Contributions included in the thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Statement of Contributions Colin Whaley is the sole author of Chapters 1, 2 and 6, which were written under the supervision of Dr. Kelly Grindrod. Three manuscripts for publication are included in this thesis. The work in Chapters 3, 4 and 5 were conducted under grants from the Canadian Institutes of Health Research (CIHR) and Telus Health awarded to Dr. Kelly Grindrod and Dr. Catherine Burns. This research was conducted at the University of Waterloo by Colin Whaley under the supervision of Dr. Kelly Grindrod. Dr. Kelly Grindrod, Dr. Catherine Burns, Dr. Reicelis Casares Li and Thana Hussein contributed to study design and partricpant recruitment. Dr. Ashley Bancsi, Dr. Reicelis Casares Li, Thana Hussein and Cassandra Sum wrote the interview questions located in the Appendicies and conducted the interviews. Dr. Kelly Grindrod, Dr. Catherine Burns, Dr. Joanne Ho, Dr. Tejal Patel and Colin Whaley contributed to the development of the research questions answered herein. Dr. Kelly Grindrod and Colin Whaley participated in coding and analysis.
    [Show full text]